Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition) | Zendy

Jian Zhou | Zendy; HuiChuan Sun | Zendy; Zheng Wang | Zendy; WenMing Cong | Zendy; Jianhua Wang | Zendy; Mengsu Zeng | Zendy; Jia-Mei Yang | Zendy; Ping Bie | Zendy; Lian-xin Liu | Zendy; Tianfu Wen | Zendy; Guo-Hong Han | Zendy; Maoqiang Wang | Zendy; Rui-Bao Liu | Zendy; Ligong Lu | Zendy; Zheng-Gang Ren | Zendy; Min-Shan Chen | Zendy; ZhaoChong Zeng | Zendy; Ping Liang | Zendy; Changhong Liang | Zendy; Min Chen | Zendy; Fuhua Yan | Zendy; Wen-Ping Wang | Zendy; Yuan Ji | Zendy; Wen-Wu Cheng | Zendy; Chao-liu Dai | Zendy; Wei-Dong Jia | Zendy; Ya-Ming Li | Zendy; YeXiong Li | Zendy; Jun Liang | Zendy; Tian-Shu Liu | Zendy; Guoyue Lv | Zendy; Yi-Lei Mao | Zendy; Wei-Xin Ren | Zendy; Hong-Cheng Shi | Zendy; Wen-Tao Wang | Zendy; Xiaoying Wang | Zendy; Bao-Cai Xing | Zendy; Jian-Ming Xu | Zendy; Jian-Yong Yang | Zendy; Ye-Fa Yang | Zendy; Sheng-Long Ye | Zendy; Zheng-Yu Yin | Zendy; Bo-Heng Zhang | Zendy; Shui-jun Zhang | Zendy; Wei-Ping Zhou | Zendy; Ji-Ye Zhu | Zendy; Rong Liu | Zendy; Ying-Hong Shi | Zendy; Yong-Sheng Xiao | Zendy; Zhi Dai | Zendy; GaoJun Teng | Zendy; Jian-qiang Cai | Zendy; Wei–Lin Wang | Zendy; Jiahong Dong | Zendy; Qiang Li | Zendy; Feng Shen | Zendy; Shu-Kui Qin | Zendy; Jia Fan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

Author(s) -

Jian Zhou,

HuiChuan Sun,

Zheng Wang,

WenMing Cong,

Jianhua Wang,

Mengsu Zeng,

Jia-Mei Yang,

Ping Bie,

Lian-xin Liu,

Tianfu Wen,

Guo-Hong Han,

Maoqiang Wang,

Rui-Bao Liu,

Ligong Lu,

Zheng-Gang Ren,

Min-Shan Chen,

ZhaoChong Zeng,

Ping Liang,

Changhong Liang,

Min Chen,

Fuhua Yan,

Wen-Ping Wang,

Yuan Ji,

Wen-Wu Cheng,

Chao-liu Dai,

Wei-Dong Jia,

Ya-Ming Li,

YeXiong Li,

Jun Liang,

Tian-Shu Liu,

Guoyue Lv,

Yi-Lei Mao,

Wei-Xin Ren,

Hong-Cheng Shi,

Wen-Tao Wang,

Xiaoying Wang,

Bao-Cai Xing,

Jian-Ming Xu,

Jian-Yong Yang,

Ye-Fa Yang,

Sheng-Long Ye,

Zheng-Yu Yin,

Bo-Heng Zhang,

Shui-jun Zhang,

Wei-Ping Zhou,

Ji-Ye Zhu,

Rong Liu,

Ying-Hong Shi,

Yong-Sheng Xiao,

Zhi Dai,

GaoJun Teng,

Jian-qiang Cai,

Wei–Lin Wang,

Jiahong Dong,

Qiang Li,

Feng Shen,

Shu-Kui Qin,

Jia Fan

Publication year - 2018

Publication title -

liver cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.916

H-Index - 34

eISSN - 2235-1795

pISSN - 1664-5553

DOI - 10.1159/000488035

Subject(s) - medicine , guideline , hepatocellular carcinoma , china , malignancy , liver cancer , hepatitis b , chronic hepatitis , cancer , family medicine , commission , pathology , immunology , political science , law , virus

Hepatocellular carcinoma (HCC) (about 85-90% of primary liver cancer) is particularly prevalent in China because of the high prevalence of chronic hepatitis B infection. HCC is the fourth most common malignancy and the third leading cause of tumor-related deaths in China. It poses a significant threat to the life and health of Chinese people.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research